awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37958038-7161F7E1-E2DF-47BC-AFFF-2F57FFB46319
Q37958038-7161F7E1-E2DF-47BC-AFFF-2F57FFB46319
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37958038-7161F7E1-E2DF-47BC-AFFF-2F57FFB46319
Progress and contrasts of the development of tivozanib for therapy of kidney cancer.
P2860
Q37958038-7161F7E1-E2DF-47BC-AFFF-2F57FFB46319
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37958038-7161F7E1-E2DF-47BC-AFFF-2F57FFB46319
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
078d8bceb3a64589a1118195d271c1878d4f7305
P2860
Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.